Unless you have been hibernating for the past few years, it has been impossible to miss the revolution in obesity and metabolic disorder management brought about by GLP-1 therapies. GLP-1 receptor agonists, and newer dual incretin agonists, have produced levels of weight loss that were previously difficult to achieve without bariatric surgery.
But as Body Weight falls, A Key Question Remains: What Exactly is Being Lost?
Weight loss is not the same as fat loss, and fat loss is not uniform. A reduction in visceral fat, liver fat, subcutaneous fat, skeletal muscle, or intramuscular fat may carry very different metabolic implications.
These questions are highly relevant in clinical trials, but they begin much earlier in the development pathway, including in small-animal models. In both settings, non-invasive imaging has a crucial role to play. MRI and DEXA can both provide accurate fat quantification but they answer different questions and needs.
Dual-energy X-ray absorptiometry, or DEXA, has long been a practical tool for body composition assessment. It is quick, widely available, low-radiation, and automatically provides useful estimates of total fat mass, lean mass, and bone mineral content. For broad monitoring and large-scale studies, it remains highly valuable.
MRI, however, offers a more detailed picture. It directly images the body in three dimensions and can quantify visceral and subcutaneous adipose tissue, liver fat, pancreatic fat, muscle volume, and muscle fat infiltration without ionising radiation. This matters in the incretin era, where large and rapid weight loss makes tissue-specific change increasingly important.
The Question is No Longer Simply: “How Much Weight Was Lost?”
It is now: “What tissue was lost, where was it lost from, and what does that mean metabolically?” with organ health, tissue quality, and muscle preservation in mind.
DEXA can help quantify overall change. MRI can reveal the anatomy and quality of that change.
In short, the scale tells us that the body is smaller. DEXA tells us broadly how fat and lean mass have changed. MRI shows us where metabolic change is happening.
Quantitative Body Composition, Simplified
These considerations apply not only to clinical trials but also to basic research and preclinical drug development in small animals. At Scintica Instrumentation, we offer a full portfolio for body composition analysis, including both iNSiGHT DEXA or M-SeriesTM MRI .
Our MRI systems, the M-SeriesTM, are designed to make this level of body composition insight more accessible. With straightforward siting, cost-effective operation, and rapid onboarding, they lower the traditional barriers to MRI adoption, even for teams with no prior MRI background.
MRI is inherently well suited to body composition imaging. It provides excellent soft-tissue contrast because water and fat exhibit different properties when placed in a strong magnetic field. One of these properties is the spin-lattice relaxation time, or T1.
MRI physics can quickly become complex, but the key point is simple: T1-weighted imaging, a conventional MRI scan, is fat-sensitive. It highlights anatomy and makes fat depots clearly visible, with fat appearing bright, as shown in the figure below.
Dixon sequences go one step further. They separate fat and water signals, enabling quantitative assessment of adipose tissue, muscle composition, and organ fat. The result is a three-dimensional, organ-resolved, quantitative view of body composition.
Body composition analysis with the M-SeriesTM compact MRI system
Conclusion
In summary, success in the fight against obesity and metabolic disorders is no longer defined by weight reduction alone. It is increasingly defined by organ health, tissue quality, and muscle preservation. Imaging is a crucial tool to quantify this change.
iNSiGHT DEXA or M-SeriesTM MRI ? it depends on the research question, the scale of your study and if spatial information matters.
At Scintica, our mission is to help scientists find the right instruments for their preclinical research. We would be delighted to advise on the methodology best suited to your study design, biological question, and throughput requirements.
